4-6 Only three GLP-1 medications are currently FDA approved for weight loss: liraglutide (Saxenda), semaglutide (Wegovy) and tirzepatide (Zepbound)
Compounded semaglutide, which the FDA has allowed under shortage provisions and which sells for $100 to $200 per month, is not a patented product
Among those experiencing greater than 20% body weight reduction, the incidence rose to 5.3%highlighting the connection between rapid weight loss and hair shedding
Other questions also warrant further research, such as understanding why some patients with OSA dont fully respond to GLP-1 treatments
This combination helps reduce sugar cravings, maintain steady energy, and support a healthy metabolic rate throughout the day
The diagnosis of occupational asthma is based both on the clinical signs of the disease and the demonstration of the occurrence of a recognized allergen in the patient's workplace